$63.46 +2.28 (%) AbbVie Inc - NYSE

Oct. 31, 2014 | 04:00 PM

Partner Headlines

  1. Humira Lifts AbbVie Earnings

    IBD | Oct. 31, 2014 | 19:03PM EST
  2. Investors Rewarded With Treats, Not Tricks, As Dow And S&P Close At Records High

    Benzinga | Oct. 31, 2014 | 16:54PM EST
  3. AbbVie Beats Q3 Earnings Estimates, Raises Guidance

    IBD | Oct. 31, 2014 | 14:25PM EST
  4. Mylan Rises On Q3 Earnings Beat, Affirms Abbott Deal

    IBD | Oct. 31, 2014 | 11:17AM EST
  5. UPDATE: AbbVie Posts Stronger-Than-Expected Q3 Results, Lifts Outlook

    Benzinga | Oct. 31, 2014 | 08:52AM EST
  6. #PreMarket Primer: Friday, October 31: BOJ Spooked By Lackluster Growth And Inflation

    Benzinga | Oct. 31, 2014 | 08:15AM EST
  7. Earnings Scheduled For October 31, 2014

    Benzinga | Oct. 31, 2014 | 05:13AM EST
  8. Amgen Refuses To Split, But Plans Hearten Investors

    IBD | Oct. 28, 2014 | 14:18PM EST
  9. Receptos Soars After Lead Drug Racks Up Another Win

    IBD | Oct. 28, 2014 | 11:46AM EST
  10. Allergan Lifts Guidance; Valeant Suggests Higher Bid

    IBD | Oct. 27, 2014 | 12:17PM EST
  11. My 5 Favorite Stocks With Dividend Growth Of The Week

    GuruFocus | Oct. 27, 2014 | 12:09PM EST
  12. Shire: Who Needs AbbVie?

    IBD | Oct. 24, 2014 | 18:46PM EST
  13. Shire EPS Growth Accelerates, Stock Continues Rebound

    IBD | Oct. 24, 2014 | 11:12AM EST
  14. Gilead's Hep C Dream Drug Faces Demanding Investors

    IBD | Oct. 22, 2014 | 16:44PM EST
  15. Making Money With Charles Payne: 10/20/14

    FoxBusiness | Oct. 21, 2014 | 18:00PM EST
  16. Celgene Reports More Good Crohn's Disease Data

    IBD | Oct. 21, 2014 | 11:32AM EST
  17. #PreMarket Primer: Tuesday, October 21: China's Third Quarter Growth Disappoints

    Benzinga | Oct. 21, 2014 | 07:45AM EST
  18. Must Watch Stocks For October 21, 2014

    Benzinga | Oct. 21, 2014 | 04:04AM EST
  19. AbbVie Unveils $5 Billion Buyback; Blames U.S. For Failed Inversion

    Benzinga | Oct. 20, 2014 | 20:20PM EST
  20. Benzinga's M&A Chatter for Monday October 20, 2014

    Benzinga | Oct. 20, 2014 | 19:27PM EST
  21. ABBVIE

    IBD | Oct. 20, 2014 | 18:57PM EST
  22. Announcement Of Termination Of Proposed AbbVie And Shire Transaction

    Benzinga | Oct. 20, 2014 | 17:13PM EST
  23. Enanta Pharma Reports Update on Collaboration Deal with AbbVie: Will Not Exercise Option for Co-Development, Co. Received $57M Related to Signing, $95M in Milestones

    Benzinga | Oct. 20, 2014 | 16:56PM EST
  24. Celgene's Crohn's Disease Drug Hits Its Marks

    IBD | Oct. 20, 2014 | 11:16AM EST
  25. Benzinga's Weekend M&A Chatter

    Benzinga | Oct. 19, 2014 | 21:58PM EST
  26. UPDATE: Bank Of America Reiterates On AbbVie On Move To Standalone Valuation

    Benzinga | Oct. 17, 2014 | 09:44AM EST
  27. Benzinga's M&A Chatter for Thursday October 16, 2014

    Benzinga | Oct. 17, 2014 | 00:02AM EST
  28. Shire may have to go it alone

    IBD | Oct. 16, 2014 | 18:59PM EST
  29. Shire Can Thrive Without AbbVie, Say Analysts

    IBD | Oct. 16, 2014 | 11:19AM EST
  30. Benzinga's Volume Movers

    Benzinga | Oct. 16, 2014 | 10:36AM EST
  31. Wall Street Drops on Continued Global Concerns

    FoxBusiness | Oct. 16, 2014 | 10:10AM EST
  32. AbbVie Board To Shareholders: Vote No On Shire Buy

    IBD | Oct. 16, 2014 | 00:52AM EST
  33. CNBC's Stock Pops & Drops From October 15: Twitter, Gogo And GoPro

    Benzinga | Oct. 15, 2014 | 20:30PM EST
  34. Benzinga's M&A Chatter for Wednesday October 15, 2014

    Benzinga | Oct. 15, 2014 | 20:01PM EST
  35. AbbVie Rethinking Shire Deal

    IBD | Oct. 15, 2014 | 18:40PM EST
  36. Was Celgene's Crohn's Disease Drug Worth The Price?

    IBD | Oct. 15, 2014 | 17:39PM EST
  37. Markets Rebound After Getting Crushed Intraday, Still Close Lower

    Benzinga | Oct. 15, 2014 | 16:57PM EST
  38. KeyCorp Falls On Downbeat Results; Penford Shares Climb

    Benzinga | Oct. 15, 2014 | 15:15PM EST
  39. Google Spending Impact On Q3 Profit Margins Eyed

    IBD | Oct. 15, 2014 | 14:33PM EST
  40. Dow Tumbles More Than 300 Points; CSR Plc Shares Surge On Acquisition News

    Benzinga | Oct. 15, 2014 | 13:49PM EST
  41. Shire Falls, AbbVie Questioned On Buyout Backtrack

    IBD | Oct. 15, 2014 | 13:11PM EST
  42. Markets Drop; Bank Of America Posts Upbeat Earnings

    Benzinga | Oct. 15, 2014 | 11:15AM EST
  43. Stocks Dive, Then Pare Losses; Shire, Expedia, KeyCorp Crumble

    IBD | Oct. 15, 2014 | 10:37AM EST
  44. Bank Of America: AbbVie's Decision To Reconsider Merger With Shire 'A Surprise To Us'

    Benzinga | Oct. 15, 2014 | 10:32AM EST
  45. Morning Market Losers

    Benzinga | Oct. 15, 2014 | 09:57AM EST
  46. Stock Futures Swoon After Data; Shire Plunges As AbbVie Balks

    IBD | Oct. 15, 2014 | 09:02AM EST
  47. Shire Shares Plummet On Possible Buyout Cancellation

    Benzinga | Oct. 15, 2014 | 08:55AM EST
  48. Benzinga's Top #PreMarket Losers

    Benzinga | Oct. 15, 2014 | 08:13AM EST
  49. Fast Money Halftime Report Final Trade From October 14

    Benzinga | Oct. 14, 2014 | 16:50PM EST
  50. AbbVie Reports Late-Breaking Results from Phase 3 Trial of HUMIRA, Has Met Primary Endpoint in PIONEER II

    Benzinga | Oct. 13, 2014 | 09:21AM EST
Trading Center